These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24999434)

  • 1. Leg spasticity and ambulation in multiple sclerosis.
    Balantrapu S; Sosnoff JJ; Pula JH; Sandroff BM; Motl RW
    Mult Scler Int; 2014; 2014():649390. PubMed ID: 24999434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerometry as a measure of walking behavior in multiple sclerosis.
    Motl RW; Pilutti L; Sandroff BM; Dlugonski D; Sosnoff JJ; Pula JH
    Acta Neurol Scand; 2013 Jun; 127(6):384-90. PubMed ID: 23240822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of spasticity on mobility and balance in persons with multiple sclerosis.
    Sosnoff JJ; Gappmaier E; Frame A; Motl RW
    J Neurol Phys Ther; 2011 Sep; 35(3):129-32. PubMed ID: 21934374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis.
    Adusumilli G; Lancia S; Levasseur VA; Amblee V; Orchard M; Wagner JM; Naismith RT
    PLoS One; 2018; 13(6):e0198178. PubMed ID: 29879144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further validation of multiple sclerosis walking scale-12 scores based on spatiotemporal gait parameters.
    Pilutti LA; Dlugonski D; Sandroff BM; Suh Y; Pula JH; Sosnoff JJ; Motl RW
    Arch Phys Med Rehabil; 2013 Mar; 94(3):575-8. PubMed ID: 22960049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further validation of the Six-Spot Step Test as a measure of ambulation in multiple sclerosis.
    Sandroff BM; Motl RW; Sosnoff JJ; Pula JH
    Gait Posture; 2015 Jan; 41(1):222-7. PubMed ID: 25455207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis.
    Balantrapu S; Sandroff BM; Sosnoff JJ; Motl RW
    ISRN Neurol; 2012; 2012():675431. PubMed ID: 22462022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early outcomes after intrathecal baclofen therapy in ambulatory patients with multiple sclerosis.
    Lee BS; Jones J; Lang M; Achey R; Dai L; Lobel DA; Nagel SJ; Machado AG; Bethoux F
    J Neurosurg; 2018 Oct; 129(4):1056-1062. PubMed ID: 29192855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between body composition and walking outcomes in multiple sclerosis.
    Jeng B; Motl RW
    Mult Scler Relat Disord; 2022 Dec; 68():104242. PubMed ID: 36274282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energetic cost of walking and spasticity in persons with multiple sclerosis with moderate disability.
    Jeng B; Sandroff BM; Motl RW
    NeuroRehabilitation; 2018; 43(4):483-489. PubMed ID: 30400119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity and Reliability of Four Clinical Gait Measures in Patients with Multiple Sclerosis.
    Bennett SE; Bromley LE; Fisher NM; Tomita MR; Niewczyk P
    Int J MS Care; 2017; 19(5):247-252. PubMed ID: 29070965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis.
    Kremer TR; Van Dillen LR; Wagner JM
    J Rehabil Res Dev; 2014; 51(6):975-84. PubMed ID: 25356797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do depressive and anxiety symptoms influence the construct validity of Multiple Sclerosis Walking Scale-12 scores?
    Šilić P; Jones CD; Jeng B; Motl RW
    Rehabil Psychol; 2024 May; 69(2):129-134. PubMed ID: 38166293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.
    Fritz NE; Jiang A; Keller J; Zackowski KM
    Arch Phys Med Rehabil; 2016 Apr; 97(4):507-512. PubMed ID: 26577146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of minimal clinically important difference values for the multiple sclerosis walking scale-12?
    Motl RW; Learmonth YC; Pilutti LA; Dlugonski D; Klaren R
    Eur Neurol; 2014; 71(3-4):196-202. PubMed ID: 24457548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study.
    Kalron A; Ehling R; Baert I; Smedal T; Rasova K; Heric-Mansrud A; Elorriage I; Nedeljkovic U; Tachino A; Gargul L; Gusowski K; Cattaneo D; Borgers S; Hebert J; Dalgas U; Feys P
    Mult Scler Relat Disord; 2020 Nov; 46():102511. PubMed ID: 32949848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying gait impairment in multiple sclerosis using GAITRite technology.
    Sosnoff JJ; Weikert M; Dlugonski D; Smith DC; Motl RW
    Gait Posture; 2011 May; 34(1):145-7. PubMed ID: 21531562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the impact of fatigue related to walking capacity and perceived ability in persons with multiple sclerosis? A multicenter study.
    Dalgas U; Langeskov-Christensen M; Skjerbæk A; Jensen E; Baert I; Romberg A; Santoyo Medina C; Gebara B; Maertens de Noordhout B; Knuts K; Béthoux F; Rasova K; Severijns D; Bibby BM; Kalron A; Norman B; Van Geel F; Wens I; Feys P
    J Neurol Sci; 2018 Apr; 387():179-186. PubMed ID: 29571860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.